OncLive® On Air
Episodes
S5 Ep33: Chachoua on Leveraging Screening Opportunities in Lung Cancer
16 Aug 2021
Contributed by Lukas
Dr. Chachoua discusses key guidelines for lung cancer screening, the psychological and financial implications of screening, and the opportunities of a...
S5 Ep32: Making the Most of Molecular Testing in Breast Cancer
12 Aug 2021
Contributed by Lukas
Drs. Brown and Kurzrock discuss the current and future applications of next-generation sequencing in breast cancer, the role of tissue-based testing i...
S5 Ep31: FDA Approval Insights: Isatuximab Plus Carfilzomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
09 Aug 2021
Contributed by Lukas
Dr. Moreau discusses the FDA approval of isatuximab-irfc plus carfilzomib and dexamethasone in relapsed/refractory multiple myeloma, key findings from...
S5 Ep30: Research Reflections: Weber Relays Melanoma Updates From the 2021 ASCO Annual Meeting
05 Aug 2021
Contributed by Lukas
Dr. Weber discusses exciting research presented during the 2021 ASCO Annual Meeting in melanoma with combination and single-agent checkpoint inhibitor...
S5 Ep29: Rariy Reviews In-Home Infusion Initiative in Oncology
02 Aug 2021
Contributed by Lukas
Chevon M. Rariy, MD, discusses how the implementation of telehealth during the COVID-19 pandemic shed light on the need for increased access to care f...
S5 Ep28: Understanding Actionable Pathogenic Variants Among Caribbean Patients With Breast and Ovarian Cancers
29 Jul 2021
Contributed by Lukas
Dr. George and Dr. Hurley discuss the data generated from their study on the correlation between deleterious variants in genes and the development of ...
S5 Ep27: Analyzing the Advancing Applications for Next-Generation Sequencing in Lung Cancer
26 Jul 2021
Contributed by Lukas
Drs Brown and Hussain discuss the current and future applications of next-generation sequencing in lung cancer, the role of tissue-based testing in li...
S5 Ep26: FDA Approval Insights: Sacituzumab Govitecan in Urothelial Cancer
22 Jul 2021
Contributed by Lukas
Dr. Tagawa discusses the FDA approval of sacituzumab govitecan in urothelial cancer, key efficacy and safety data from the pivotal TROPHY-U-01 trial, ...
S5 Ep25: Jabbour on Tailoring Treatment With TKIs in CML and Ph+ ALL
19 Jul 2021
Contributed by Lukas
Dr. Jabbour discusses the optimal use of ponatinib in chronic myeloid leukemia and data from the 2021 ASCO Annual Meeting with the combination of blin...
S5 Ep24: Mayer on the Optimization of SERDs in ER+ Breast Cancer
15 Jul 2021
Contributed by Lukas
Dr. Mayer discusses the mechanism of action of SERDs in ER-positive breast cancer, highlighted data from the AMEERA-1 trial with amcenestrant and palb...
S5 Ep23: Wainberg Weighs In on Advances in HER2+ GI Cancers
12 Jul 2021
Contributed by Lukas
In our exclusive interview, Wainberg discussed factors that help steer treatment selection in HER2-positive gastrointestinal malignancies, advances on...
S5 Ep22: CTCA Leaders Provide Post-Pandemic Predictions in Oncology
08 Jul 2021
Contributed by Lukas
Dr. Rariy, Ms. Brown, and Ms. Greenman discuss how the COVID-19 pandemic has led to a significant delay in cancer diagnoses, impacted the training of ...
S5 Ep21: Research Reflections: O'Malley Relays Key Updates in Ovarian and Endometrial Cancers
05 Jul 2021
Contributed by Lukas
Dr. O’Malley discusses key findings from 6 trials that were presented at the virtual 2021 SGO Annual Meeting on Women’s Cancer.
S5 Ep20: Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer
01 Jul 2021
Contributed by Lukas
Dr. Sherman discusses the incidence of RET fusions in medullary thyroid cancer and the current clinical landscape of RET inhibitors in the field.